Vincenzo Micale

Summary

Country: Italy

Publications

  1. ncbi request reprint Therapeutic potential of cannabinoids in schizophrenia
    Jana Kucerova
    CEITEC Central European Institute of Technology Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
    Recent Pat CNS Drug Discov 9:13-25. 2014
  2. pmc The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
    Ana Luisa Terzian
    Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry Munich, Germany
    Front Behav Neurosci 5:49. 2011
  3. doi request reprint Endocannabinoid system and mood disorders: priming a target for new therapies
    Vincenzo Micale
    CEITEC Central European Institute of Technology Masaryk University, Brno, Czech Republic
    Pharmacol Ther 138:18-37. 2013
  4. doi request reprint Leading compounds for the validation of animal models of psychopathology
    Vincenzo Micale
    CEITEC Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
    Cell Tissue Res 354:309-30. 2013

Collaborators

  • Vincenzo Di Marzo
  • Jana Kucerova
  • Filippo Drago
  • Ana Luisa Terzian
  • Katarina Tabiova
  • Carsten T Wotjak

Detail Information

Publications4

  1. ncbi request reprint Therapeutic potential of cannabinoids in schizophrenia
    Jana Kucerova
    CEITEC Central European Institute of Technology Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
    Recent Pat CNS Drug Discov 9:13-25. 2014
    ..Furthermore, this review will be highlighting the therapeutic potential of cannabinoid-related compounds and presenting some promising patents targeting potential treatment options for schizophrenia. ..
  2. pmc The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
    Ana Luisa Terzian
    Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry Munich, Germany
    Front Behav Neurosci 5:49. 2011
    ..These results provided first direct evidence for a cross-talk between dopaminergic D1Rs and endocannabinoid system in terms of controlling negative affect...
  3. doi request reprint Endocannabinoid system and mood disorders: priming a target for new therapies
    Vincenzo Micale
    CEITEC Central European Institute of Technology Masaryk University, Brno, Czech Republic
    Pharmacol Ther 138:18-37. 2013
    ..The state of the art of the possible therapeutic use of endocannabinoid deactivation inhibitors and phytocannabinoids in mood disorders is discussed in this review article...
  4. doi request reprint Leading compounds for the validation of animal models of psychopathology
    Vincenzo Micale
    CEITEC Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
    Cell Tissue Res 354:309-30. 2013
    ..We conclude that the generation of convincing and useful animal models of mental illnesses could be a bridge to success in drug discovery...